Atlas Trials

Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia

Clinical trial NCT07157722 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07157722
Sponsor
Tanta University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Beta Thalassemia
Start date
2025-08-30
Primary completion
2025-12-30
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.